Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ardelyx, Inc. (ARDX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ardelyx, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1437402.
Total stock buying since 2015: $685,392,043.
Total stock sales since 2015: $43,231,513.
Total stock option exercises since 2015: $2,014,301.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 1,158,106 | $4,784,370 | 494,727 | $2,584,188 | 254,166 | $207,621 |
| 2024 | 215,868 | $996,662 | 1,505,564 | $11,147,369 | 693,888 | $1,224,644 |
| 2023 | 0 | $0 | 539,979 | $2,731,579 | 108,333 | $188,248 |
| 2022 | 2,889,000 | $5,037,201 | 629,644 | $566,452 | 0 | $0 |
| 2021 | 0 | $0 | 5,890,134 | $7,577,251 | 285,392 | $154,111 |
| 2020 | 315,644 | $1,998,216 | 680,999 | $4,289,107 | 78,123 | $136,452 |
| 2019 | 66 | $495 | 97,167 | $295,257 | 30,000 | $45,000 |
| 2018 | 10,000 | $40,000 | 25,779 | $73,294 | 0 | $0 |
| 2017 | 0 | $0 | 26,700 | $263,494 | 6,000 | $3,240 |
| 2016 | 39,188,162 | $361,783,231 | 27,045 | $335,943 | 21,000 | $20,905 |
| 2015 | 29,033,691 | $310,751,868 | 554,269 | $13,367,579 | 51,727 | $34,080 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-02-21 | Rosenbaum David P. (Chief Development Officer) | Sale | 4,508 | 3.00 | 13,528 |
| 2023-02-21 | Raab Michael (President & CEO) | Sale | 13,449 | 3.00 | 40,360 |
| 2022-11-22 | Williams Laura A (Chief Medical Officer) | Sale | 2,482 | 1.95 | 4,826 |
| 2022-11-22 | Blanks Robert (See Remarks) | Sale | 2,928 | 1.94 | 5,692 |
| 2022-11-22 | Rodriguez Susan (Chief Commercial Officer) | Sale | 6,912 | 1.95 | 13,442 |
| 2022-11-22 | Rosenbaum David P. (Chief Development Officer) | Sale | 3,896 | 1.95 | 7,580 |
| 2022-11-22 | Renz Justin A (Chief Financial Officer) | Sale | 3,008 | 1.95 | 5,850 |
| 2022-11-22 | Raab Michael (President & CEO) | Sale | 12,438 | 1.94 | 24,178 |
| 2022-11-22 | Grammer Elizabeth A (See Remarks) | Sale | 2,484 | 1.95 | 4,830 |
| 2022-11-17 | Mott David M | Buy | 1,701,000 | 1.76 | 3,002,265 |
| 2022-10-05 | Blanks Robert (See Remarks) | Sale | 100,000 | 1.50 | 150,000 |
| 2022-09-01 | Rosenbaum David P. (Chief Development Officer) | Sale | 6,000 | .92 | 5,520 |
| 2022-08-31 | Felsch Robert Ora (See Remarks) | Buy | 6,000 | .62 | 3,714 |
| 2022-08-31 | Williams Laura A (Chief Medical Officer) | Buy | 6,000 | .62 | 3,714 |
| 2022-08-31 | Rosenbaum David P. (Chief Development Officer) | Buy | 6,000 | .62 | 3,714 |
| 2022-08-31 | Renz Justin A (Chief Financial Officer) | Buy | 6,000 | .62 | 3,714 |
| 2022-08-31 | Raab Michael (President & CEO) | Buy | 6,000 | .62 | 3,714 |
| 2022-08-31 | Grammer Elizabeth A (See Remarks) | Buy | 6,000 | .62 | 3,714 |
| 2022-08-22 | Williams Laura A (Chief Medical Officer) | Sale | 1,276 | .98 | 1,253 |
| 2022-08-22 | Blanks Robert (See Remarks) | Sale | 1,458 | .98 | 1,431 |
| 2022-08-22 | Rodriguez Susan (Chief Commercial Officer) | Sale | 3,420 | .98 | 3,358 |
| 2022-08-22 | Rosenbaum David P. (Chief Development Officer) | Sale | 1,955 | .98 | 1,919 |
| 2022-08-22 | Renz Justin A (Chief Financial Officer) | Sale | 1,498 | .98 | 1,469 |
| 2022-08-22 | Raab Michael (President & CEO) | Sale | 6,146 | .98 | 6,029 |
| 2022-08-22 | Grammer Elizabeth A (See Remarks) | Sale | 1,236 | .98 | 1,212 |
| 2022-07-26 | Blanks Robert (See Remarks) | Sale | 5,188 | .67 | 3,475 |
| 2022-06-06 | Blanks Robert (See Remarks) | Sale | 73,312 | .64 | 47,139 |
| 2022-06-06 | Rodriguez Susan (Chief Commercial Officer) | Sale | 43,920 | .64 | 28,240 |
| 2022-06-06 | Rosenbaum David P. (Chief Development Officer) | Sale | 61,640 | .64 | 39,634 |
| 2022-06-06 | Renz Justin A (Chief Financial Officer) | Sale | 73,312 | .64 | 47,139 |
| 2022-06-06 | Raab Michael (President & CEO) | Sale | 103,624 | .64 | 66,630 |
| 2022-06-06 | Grammer Elizabeth A (See Remarks) | Sale | 60,821 | .64 | 39,107 |
| 2022-05-20 | Blanks Robert (See Remarks) | Sale | 1,489 | .67 | 999 |
| 2022-05-20 | Rodriguez Susan (Chief Commercial Officer) | Sale | 3,425 | .67 | 2,298 |
| 2022-05-20 | Rosenbaum David P. (Chief Development Officer) | Sale | 2,013 | .67 | 1,350 |
| 2022-05-20 | Renz Justin A (Chief Financial Officer) | Sale | 1,528 | .67 | 1,025 |
| 2022-05-20 | Raab Michael (President & CEO) | Sale | 12,248 | .67 | 8,218 |
| 2022-05-20 | Grammer Elizabeth A (See Remarks) | Sale | 2,526 | .67 | 1,694 |
| 2021-12-15 | Baskett Forest (10% Owner) | Sale | 1,211,352 | 1.14 | 1,384,575 |
| 2021-12-15 | Sandell Scott D (10% Owner) | Sale | 1,211,352 | 1.14 | 1,384,575 |
| 2021-12-14 | Baskett Forest (10% Owner) | Sale | 1,000,735 | 1.24 | 1,244,914 |
| 2021-12-14 | Sandell Scott D (10% Owner) | Sale | 1,000,735 | 1.24 | 1,244,914 |
| 2021-12-09 | Baskett Forest (10% Owner) | Sale | 669,483 | 1.51 | 1,012,927 |
| 2021-12-09 | Sandell Scott D (10% Owner) | Sale | 669,483 | 1.51 | 1,012,927 |
| 2021-11-22 | Blanks Robert (See Remarks) | Sale | 643 | .99 | 637 |
| 2021-11-22 | Rodriguez Susan (Chief Commercial Officer) | Sale | 643 | .99 | 637 |
| 2021-11-22 | Rosenbaum David P. (Chief Development Officer) | Sale | 827 | .99 | 820 |
| 2021-11-22 | Jacobs Jeffrey W (Chief Scientific Officer) | Sale | 5,754 | .98 | 5,661 |
| 2021-11-22 | Renz Justin A (Chief Financial Officer) | Sale | 643 | .99 | 637 |
| 2021-11-22 | Raab Michael (President & CEO) | Sale | 2,607 | .99 | 2,586 |
| 2021-11-22 | Grammer Elizabeth A (See Remarks) | Sale | 537 | .99 | 532 |
| 2021-11-15 | Jacobs Jeffrey W (Chief Scientific Officer) | Sale | 5,000 | 1.13 | 5,649 |
| 2021-11-12 | Grammer Elizabeth A (See Remarks) | Sale | 77,432 | 1.12 | 87,111 |
| 2021-11-08 | Jacobs Jeffrey W (Chief Scientific Officer) | Sale | 2,166 | 1.18 | 2,555 |
| 2021-08-20 | Blanks Robert (See Remarks) | Sale | 631 | 1.32 | 832 |
| 2021-08-20 | Rodriguez Susan (Chief Commercial Officer) | Sale | 630 | 1.32 | 831 |
| 2021-08-20 | Rosenbaum David P. (Chief Development Officer) | Sale | 807 | 1.32 | 1,065 |
| 2021-08-20 | Jacobs Jeffrey W (Chief Scientific Officer) | Sale | 741 | 1.32 | 978 |
| 2021-08-20 | Renz Justin A (Chief Financial Officer) | Sale | 631 | 1.32 | 832 |
| 2021-08-20 | Raab Michael (President & CEO) | Sale | 2,573 | 1.32 | 3,396 |
| 2021-08-20 | Grammer Elizabeth A (See Remarks) | Sale | 526 | 1.32 | 694 |
| 2021-08-03 | Jacobs Jeffrey W (Chief Scientific Officer) | Option Ex | 10,000 | .54 | 5,400 |
| 2021-08-03 | Raab Michael (President & CEO) | Option Ex | 267,892 | .54 | 144,661 |
| 2021-06-15 | Jacobs Jeffrey W (Chief Scientific Officer) | Sale | 7,500 | 7.29 | 54,660 |
| 2021-06-15 | Jacobs Jeffrey W (Chief Scientific Officer) | Option Ex | 7,500 | .54 | 4,050 |
| 2021-05-28 | Rosenbaum David P. (Chief Development Officer) | Sale | 3,062 | 7.22 | 22,098 |
| 2021-05-20 | Blanks Robert (See Remarks) | Sale | 612 | 7.09 | 4,337 |
| 2021-05-20 | Rosenbaum David P. (Chief Development Officer) | Sale | 769 | 7.09 | 5,450 |
| 2021-05-20 | Jacobs Jeffrey W (Chief Scientific Officer) | Sale | 721 | 7.09 | 5,110 |
| 2021-05-20 | Renz Justin A (Chief Financial Officer) | Sale | 612 | 7.09 | 4,337 |
| 2021-04-06 | Blanks Robert (See Remarks) | Sale | 5,163 | 8.00 | 41,304 |
| 2021-02-22 | Rodriguez Susan (Chief Commercial Officer) | Sale | 611 | 6.88 | 4,205 |
| 2021-02-22 | Rosenbaum David P. (Chief Development Officer) | Sale | 805 | 6.88 | 5,540 |
| 2021-02-22 | Jacobs Jeffrey W (Chief Scientific Officer) | Sale | 702 | 6.88 | 4,831 |
| 2021-02-22 | Renz Justin A (Chief Financial Officer) | Sale | 608 | 6.88 | 4,184 |
| 2021-02-22 | Raab Michael (President & CEO) | Sale | 2,534 | 6.88 | 17,441 |
| 2021-02-22 | Grammer Elizabeth A (See Remarks) | Sale | 504 | 6.88 | 3,469 |
| 2020-12-21 | Jacobs Jeffrey W (Chief Scientific Officer) | Sale | 3,949 | 6.88 | 27,153 |
| 2020-12-14 | Grammer Elizabeth A (See Remarks) | Sale | 41,000 | 7.30 | 299,300 |
| 2020-12-14 | Grammer Elizabeth A (See Remarks) | Option Ex | 41,000 | 2.32 | 95,120 |
| 2020-12-11 | Grammer Elizabeth A (See Remarks) | Sale | 1,000 | 7.30 | 7,300 |
| 2020-12-11 | Grammer Elizabeth A (See Remarks) | Option Ex | 1,000 | 2.32 | 2,320 |
| 2020-12-10 | Mott David M | Buy | 170,000 | 5.89 | 1,000,789 |
| 2020-09-16 | Rodriguez Susan (Chief Commercial Officer) | Sale | 6,087 | 6.11 | 37,167 |
| 2020-09-16 | Jacobs Jeffrey W (SVP, Technical Operations) | Sale | 10,000 | 6.05 | 60,500 |
| 2020-09-15 | Blanks Robert (See Remarks) | Sale | 34,685 | 5.45 | 189,171 |
| 2020-09-15 | Rosenbaum David P. (Chief Development Officer) | Sale | 38,126 | 5.52 | 210,341 |
| 2020-09-15 | Jacobs Jeffrey W (SVP, Technical Operations) | Sale | 40,804 | 5.53 | 225,605 |
| 2020-09-15 | Renz Justin A (Chief Financial Officer) | Sale | 3,714 | 5.49 | 20,371 |
| 2020-09-15 | Raab Michael (President & CEO) | Sale | 106,337 | 5.61 | 596,337 |
| 2020-09-15 | Grammer Elizabeth A (See Remarks) | Sale | 28,810 | 5.37 | 154,565 |
| 2020-09-01 | Blanks Robert (See Remarks) | Sale | 2,049 | 5.58 | 11,425 |
| 2020-07-02 | Raab Michael (President & CEO) | Sale | 23,128 | 7.01 | 162,127 |
| 2020-06-25 | Mott David M | Buy | 68,373 | 6.96 | 476,012 |
| 2020-06-24 | Mott David M | Buy | 72,598 | 6.75 | 489,891 |
| 2020-06-22 | Mott David M | Buy | 4,673 | 6.75 | 31,524 |
| 2020-06-15 | Baskett Forest (10% Owner) | Sale | 43 | 6.37 | 273 |
| 2020-06-15 | Sandell Scott D (10% Owner) | Sale | 43 | 6.37 | 273 |
| 2020-06-12 | Baskett Forest (10% Owner) | Sale | 44,992 | 6.42 | 288,668 |
| 2020-06-12 | Sandell Scott D (10% Owner) | Sale | 44,992 | 6.42 | 288,668 |
| 2020-06-11 | Baskett Forest (10% Owner) | Sale | 67,891 | 6.36 | 431,515 |
| 2020-06-11 | Sandell Scott D (10% Owner) | Sale | 44,991 | 6.32 | 284,478 |
| 2020-06-01 | Raab Michael (President & CEO) | Sale | 23,128 | 7.33 | 169,643 |
| 2020-05-05 | Raab Michael (President & CEO) | Sale | 4,486 | 7.03 | 31,536 |
| 2020-05-04 | Raab Michael (President & CEO) | Sale | 15,941 | 7.01 | 111,682 |
| 2020-04-27 | Grammer Elizabeth A (See Remarks) | Sale | 17,824 | 7.50 | 133,680 |
| 2020-04-17 | Raab Michael (President & CEO) | Sale | 9,428 | 7.02 | 66,165 |
| 2020-04-16 | Raab Michael (President & CEO) | Sale | 10,500 | 7.01 | 73,647 |
| 2020-04-15 | Raab Michael (President & CEO) | Sale | 500 | 7.03 | 3,515 |
| 2020-03-02 | Raab Michael (President & CEO) | Sale | 31,551 | 7.01 | 221,077 |
| 2020-03-02 | Raab Michael (President & CEO) | Option Ex | 11,123 | 1.08 | 12,012 |
| 2020-02-05 | Raab Michael (President & CEO) | Sale | 25,000 | 7.32 | 182,925 |
| 2020-02-05 | Raab Michael (President & CEO) | Option Ex | 25,000 | 1.08 | 27,000 |
| 2019-12-30 | Grammer Elizabeth A (EVP, General Counsel) | Buy | 66 | 7.51 | 495 |
| 2019-12-03 | Grammer Elizabeth A (EVP, General Counsel) | Sale | 5,000 | 8.00 | 40,000 |
| 2019-12-03 | Grammer Elizabeth A (EVP, General Counsel) | Option Ex | 5,000 | 3.42 | 17,100 |
| 2019-11-19 | Grammer Elizabeth A (EVP, General Counsel) | Sale | 5,000 | 7.00 | 35,000 |
| 2019-11-19 | Grammer Elizabeth A (EVP, General Counsel) | Option Ex | 5,000 | 3.42 | 17,100 |
| 2019-10-07 | Kaufmann Mark (Chief Financial Officer) | Sale | 20,000 | 4.56 | 91,199 |
| 2019-10-07 | Kaufmann Mark (Chief Financial Officer) | Option Ex | 20,000 | .54 | 10,800 |
| 2019-08-22 | Grammer Elizabeth A (EVP, General Counsel) | Sale | 948 | 3.50 | 3,318 |
| 2019-08-21 | Grammer Elizabeth A (EVP, General Counsel) | Sale | 4,052 | 3.50 | 14,182 |
| 2019-08-19 | Grammer Elizabeth A (EVP, General Counsel) | Sale | 5,874 | .00 | 0 |
| 2019-06-04 | Rosenbaum David P. (Chief Development Officer) | Sale | 2,856 | 2.54 | 7,257 |
| 2019-06-04 | Kaufmann Mark (Chief Financial Officer) | Sale | 3,357 | 2.55 | 8,550 |
| 2019-06-04 | Raab Michael (President & CEO) | Sale | 10,054 | 2.54 | 25,547 |
| 2019-06-04 | Grammer Elizabeth A (SVP, General Counsel) | Sale | 2,520 | 2.54 | 6,403 |
| 2019-01-02 | Rosenbaum David P. (Chief Development Officer) | Sale | 6,386 | 1.70 | 10,868 |
| 2019-01-02 | Kaufmann Mark (Chief Financial Officer) | Sale | 6,556 | 1.70 | 11,151 |
| 2019-01-02 | Raab Michael (President & CEO) | Sale | 19,644 | 1.70 | 33,414 |
| 2019-01-02 | Grammer Elizabeth A (EVP, General Counsel) | Sale | 4,920 | 1.70 | 8,368 |
| 2018-11-13 | Rosenbaum David P. (Chief Development Officer) | Sale | 5,570 | 2.84 | 15,818 |
| 2018-11-13 | Kaufmann Mark (Chief Financial Officer) | Sale | 6,539 | 2.84 | 18,570 |
| 2018-11-13 | Raab Michael (President & CEO) | Sale | 6,539 | 2.84 | 18,570 |
| 2018-11-13 | Grammer Elizabeth A (EVP, General Counsel) | Sale | 6,539 | 2.84 | 18,570 |
| 2018-11-12 | Sandell Scott D (10% Owner) | Sale | 592 | 2.98 | 1,766 |
| 2018-05-30 | Ringold Gordon | Buy | 10,000 | 4.00 | 40,000 |
| 2017-10-24 | Seeto Reginald (Chief Operating Officer) | Sale | 10,008 | 5.20 | 52,041 |
| 2017-08-30 | Baskett Forest (10% Owner) | Sale | 485 | 4.95 | 2,400 |
| 2017-04-18 | Rosenbaum David P. (Chief Development Officer) | Sale | 2,051 | 11.98 | 24,577 |
| 2017-03-10 | Rosenbaum David P. (SVP, Drug Development) | Sale | 1,000 | 13.48 | 13,482 |
| 2017-03-03 | Caldwell Jeremy S (EVP, Chief Scientific Officer) | Sale | 1,026 | 14.14 | 14,511 |
| 2017-03-01 | Jacobs Jeffrey W (SVP, Technical Operations) | Sale | 3,000 | 13.70 | 41,100 |
| 2017-03-01 | Jacobs Jeffrey W (SVP, Technical Operations) | Option Ex | 3,000 | .54 | 1,620 |
| 2017-02-01 | Jacobs Jeffrey W (SVP, Technical Operations) | Sale | 3,000 | 12.00 | 36,000 |
| 2017-02-01 | Jacobs Jeffrey W (SVP, Technical Operations) | Option Ex | 3,000 | .54 | 1,620 |
| 2017-01-05 | Korner Paul (EVP, Chief Medical Officer) | Sale | 6,130 | 12.95 | 79,383 |
| 2016-12-16 | Rosenbaum David P. (SVP, Drug Development) | Sale | 900 | 14.48 | 13,035 |
| 2016-11-11 | Caldwell Jeremy S (EVP, Chief Scientific Officer) | Sale | 2,158 | 15.13 | 32,646 |
| 2016-10-11 | Jacobs Jeffrey W (SVP, Technical Operations) | Sale | 6,000 | 15.00 | 90,000 |
| 2016-10-11 | Jacobs Jeffrey W (SVP, Technical Operations) | Option Ex | 6,000 | .54 | 3,240 |
| 2016-09-23 | Grammer Elizabeth A (SVP, General Counsel) | Sale | 3,560 | 12.00 | 42,720 |
| 2016-09-23 | Grammer Elizabeth A (SVP, General Counsel) | Option Ex | 3,560 | 2.25 | 8,010 |
| 2016-09-22 | Grammer Elizabeth A (SVP, General Counsel) | Sale | 1,440 | 12.00 | 17,280 |
| 2016-09-22 | Grammer Elizabeth A (SVP, General Counsel) | Option Ex | 1,440 | 1.08 | 1,555 |
| 2016-09-19 | Grammer Elizabeth A (SVP, General Counsel) | Sale | 6,859 | 11.21 | 76,882 |
| 2016-09-19 | Grammer Elizabeth A (SVP, General Counsel) | Option Ex | 5,000 | 1.08 | 5,400 |
| 2016-07-18 | Nea 15 Gp, Llc (10% Owner) | Buy | 1,527,301 | 8.73 | 13,333,337 |
| 2016-07-18 | Sakoda Jon (10% Owner) | Buy | 1,527,301 | 8.73 | 13,333,337 |
| 2016-07-18 | Florence Anthony A. Jr. (10% Owner) | Buy | 1,527,301 | 8.73 | 13,333,337 |
| 2016-07-18 | Sonsini Peter W. (10% Owner) | Buy | 1,527,301 | 8.73 | 13,333,337 |
| 2016-07-18 | Viswanathan Ravi (10% Owner) | Buy | 1,527,301 | 8.73 | 13,333,337 |
| 2016-07-18 | Nea 12 Gp, Llc (10% Owner) | Buy | 763,650 | 8.73 | 6,666,664 |
| 2016-07-18 | Weller Harry R (10% Owner) | Buy | 1,527,301 | 8.73 | 13,333,337 |
| 2016-07-18 | Baskett Forest (10% Owner) | Buy | 2,290,951 | 8.73 | 20,000,002 |
| 2016-07-18 | Kolluri Krishna Kittu (10% Owner) | Buy | 2,290,951 | 8.73 | 20,000,002 |
| 2016-07-18 | Sandell Scott D (10% Owner) | Buy | 2,290,951 | 8.73 | 20,000,002 |
| 2016-07-18 | Makower Joshua (10% Owner) | Buy | 1,527,301 | 8.73 | 13,333,337 |
| 2016-07-18 | Kerins Patrick J (10% Owner) | Buy | 763,650 | 8.73 | 6,666,664 |
| 2016-07-18 | Mott David M (Director) | Buy | 1,527,301 | 8.73 | 13,333,337 |
| 2016-07-18 | Barrett M James (10% Owner) | Buy | 763,650 | 8.73 | 6,666,664 |
| 2016-07-18 | Barris Peter J (10% Owner) | Buy | 2,290,951 | 8.73 | 20,000,002 |
| 2016-03-21 | Ringold Gordon | Buy | 15,000 | 7.77 | 116,535 |
| 2016-03-03 | Rosenbaum David P. (SVP, Drug Development) | Sale | 1,128 | 10.74 | 12,110 |
| 2016-02-16 | Kaufmann Mark (Chief Financial Officer) | Sale | 5,000 | 10.25 | 51,270 |
| 2016-02-16 | Kaufmann Mark (Chief Financial Officer) | Option Ex | 5,000 | .54 | 2,700 |
| 2016-01-13 | Nea 15 Gp, Llc (10% Owner) | Buy | 1,000,000 | 10.00 | 10,000,000 |
| 2016-01-13 | Sakoda Jon (10% Owner) | Buy | 1,000,000 | 10.00 | 10,000,000 |
| 2016-01-13 | Florence Anthony A. Jr. (10% Owner) | Buy | 1,000,000 | 10.00 | 10,000,000 |
| 2016-01-13 | Sonsini Peter W. (10% Owner) | Buy | 1,000,000 | 10.00 | 10,000,000 |
| 2016-01-13 | Viswanathan Ravi (10% Owner) | Buy | 1,000,000 | 10.00 | 10,000,000 |
| 2016-01-13 | Nea 12 Gp, Llc (10% Owner) | Buy | 500,000 | 10.00 | 5,000,000 |
| 2016-01-13 | Weller Harry R (10% Owner) | Buy | 1,000,000 | 10.00 | 10,000,000 |
| 2016-01-13 | Baskett Forest (10% Owner) | Buy | 1,500,000 | 10.00 | 15,000,000 |
| 2016-01-13 | Kolluri Krishna Kittu (10% Owner) | Buy | 1,500,000 | 10.00 | 15,000,000 |
| 2016-01-13 | Sandell Scott D (10% Owner) | Buy | 1,500,000 | 10.00 | 15,000,000 |
| 2016-01-13 | Makower Joshua (10% Owner) | Buy | 1,000,000 | 10.00 | 10,000,000 |
| 2016-01-13 | Kerins Patrick J (10% Owner) | Buy | 500,000 | 10.00 | 5,000,000 |
| 2016-01-13 | Mott David M (Director) | Buy | 1,000,000 | 10.00 | 10,000,000 |
| 2016-01-13 | Barrett M James (10% Owner) | Buy | 500,000 | 10.00 | 5,000,000 |
| 2016-01-13 | Barris Peter J (10% Owner) | Buy | 1,500,000 | 10.00 | 15,000,000 |
| 2015-12-17 | Bertrand William C Jr | Buy | 5,000 | 20.00 | 100,000 |
| 2015-12-15 | Jacobs Jeffrey W (SVP, Technical Operations) | Sale | 2,000 | 20.00 | 40,000 |
| 2015-12-15 | Jacobs Jeffrey W (SVP, Technical Operations) | Option Ex | 2,000 | .54 | 1,080 |
| 2015-11-27 | Jacobs Jeffrey W (SVP, Technical Operations) | Sale | 2,000 | 20.00 | 40,000 |
| 2015-11-27 | Jacobs Jeffrey W (SVP, Technical Operations) | Option Ex | 2,000 | .54 | 1,080 |
| 2015-10-08 | Jacobs Jeffrey W (SVP, Technical Operations) | Sale | 2,000 | 19.88 | 39,760 |
| 2015-10-08 | Jacobs Jeffrey W (SVP, Technical Operations) | Option Ex | 2,000 | .54 | 1,080 |
| 2015-09-22 | Rosenbaum David P. (SVP, Drug Development) | Sale | 600 | 22.00 | 13,200 |
| 2015-09-21 | Rosenbaum David P. (SVP, Drug Development) | Sale | 800 | 22.09 | 17,674 |
| 2015-09-15 | Rosenbaum David P. (SVP, Drug Development) | Sale | 2,540 | 22.01 | 55,897 |
| 2015-09-10 | Jacobs Jeffrey W (SVP, Technical Operations) | Sale | 2,000 | 20.59 | 41,186 |
| 2015-09-10 | Jacobs Jeffrey W (SVP, Technical Operations) | Option Ex | 2,000 | .54 | 1,080 |
| 2015-09-08 | Raab Michael (President & CEO) | Sale | 9,785 | 20.29 | 198,547 |
| 2015-09-03 | Rosenbaum David P. (SVP, Drug Development) | Sale | 1,251 | 19.25 | 24,081 |
| 2015-09-01 | Caldwell Jeremy S (EVP, Chief Scientific Officer) | Sale | 643 | 18.32 | 11,779 |
| 2015-09-01 | Rosenbaum David P. (SVP, Drug Development) | Sale | 1,286 | 18.32 | 23,559 |
| 2015-09-01 | Grammer Elizabeth A (VP, General Counsel) | Sale | 893 | 18.32 | 16,359 |
| 2015-08-18 | Raab Michael (President & CEO) | Sale | 1,104 | 20.00 | 22,080 |
| 2015-08-06 | Jacobs Jeffrey W (SVP, Technical Operations) | Sale | 2,000 | 19.07 | 38,140 |
| 2015-08-06 | Jacobs Jeffrey W (SVP, Technical Operations) | Option Ex | 2,000 | .54 | 1,080 |
| 2015-08-03 | Raab Michael (President & CEO) | Sale | 300 | 20.00 | 6,000 |
| 2015-07-30 | Rosenbaum David P. (SVP, Drug Development) | Sale | 2,011 | 19.27 | 38,755 |
| 2015-07-28 | Jacobs Jeffrey W (Senior VP, Technical Ops) | Sale | 2,500 | 20.00 | 50,000 |
| 2015-07-28 | Jacobs Jeffrey W (Senior VP, Technical Ops) | Option Ex | 2,500 | .54 | 1,350 |
| 2015-07-28 | Raab Michael (President & CEO) | Sale | 2,111 | 20.00 | 42,220 |
| 2015-07-22 | Grammer Elizabeth A (VP, General Counsel) | Sale | 2,500 | 18.00 | 45,000 |
| 2015-07-22 | Grammer Elizabeth A (VP, General Counsel) | Option Ex | 2,500 | 1.08 | 2,700 |
| 2015-07-15 | Grammer Elizabeth A (VP, General Counsel) | Sale | 10,000 | 17.11 | 171,149 |
| 2015-07-15 | Grammer Elizabeth A (VP, General Counsel) | Option Ex | 5,000 | .54 | 2,700 |
| 2015-06-10 | Ringold Gordon | Buy | 10,000 | 15.19 | 151,880 |
| 2015-06-05 | Nea 12 Gp, Llc (10% Owner) | Buy | 1,869,159 | 10.70 | 20,000,001 |
| 2015-06-05 | Drant Ryan D (10% Owner) | Buy | 1,869,159 | 10.70 | 20,000,001 |
| 2015-06-05 | Baskett Forest (10% Owner) | Buy | 4,672,897 | 10.70 | 49,999,997 |
| 2015-06-05 | Kolluri Krishna Kittu (10% Owner) | Buy | 4,672,897 | 10.70 | 49,999,997 |
| 2015-06-05 | Sandell Scott D (10% Owner) | Buy | 4,672,897 | 10.70 | 49,999,997 |
| 2015-06-05 | Kerins Patrick J (10% Owner) | Buy | 1,869,159 | 10.70 | 20,000,001 |
| 2015-06-05 | Mott David M (Director) | Buy | 2,803,738 | 10.70 | 29,999,996 |
| 2015-06-05 | Barrett M James (10% Owner) | Buy | 1,869,159 | 10.70 | 20,000,001 |
| 2015-06-05 | Schultz Peter G | Buy | 46,729 | 10.70 | 500,000 |
| 2015-06-05 | Barris Peter J (10% Owner) | Buy | 4,672,897 | 10.70 | 49,999,997 |
| 2015-05-04 | Kaufmann Mark (Chief Financial Officer) | Sale | 9,083 | 10.81 | 98,232 |
| 2015-05-04 | Kaufmann Mark (Chief Financial Officer) | Option Ex | 9,083 | .54 | 4,904 |
| 2015-04-06 | Kaufmann Mark (Chief Financial Officer) | Sale | 7,681 | 12.80 | 98,332 |
| 2015-04-06 | Kaufmann Mark (Chief Financial Officer) | Option Ex | 7,681 | .54 | 4,147 |
| 2015-03-03 | Kaufmann Mark (Chief Financial Officer) | Sale | 6,075 | 15.60 | 94,745 |
| 2015-03-03 | Kaufmann Mark (Chief Financial Officer) | Option Ex | 6,075 | .54 | 3,280 |
| 2015-03-02 | Jacobs Jeffrey W (VP, Chemistry) | Sale | 981 | 15.81 | 15,513 |
| 2015-03-02 | Grammer Elizabeth A (VP, General Counsel) | Sale | 1,737 | 15.81 | 27,470 |
| 2015-03-02 | Jue George (VP, Operations) | Sale | 1,500 | 15.88 | 23,821 |
| 2015-02-04 | Jacobs Jeffrey W (VP, Chemistry) | Sale | 8,888 | 16.45 | 146,180 |
| 2015-02-04 | Jacobs Jeffrey W (VP, Chemistry) | Option Ex | 8,888 | 1.08 | 9,599 |
| 2015-01-30 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 170,000 | 27.37 | 4,652,900 |
| 2015-01-08 | Cmea Ventures Vii (parallel) Lp (10% Owner) | Sale | 300,000 | 24.25 | 7,275,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of ARDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ardelyx, Inc. (symbol ARDX, CIK number 1437402) see the Securities and Exchange Commission (SEC) website.